Christopher James Hill - 10 Sep 2025 Form 3 Insider Report for Adaptimmune Therapeutics PLC (ADAP)

Role
Chief Financial Officer
Signature
/s/ Christopher James Hill
Issuer symbol
ADAP
Transactions as of
10 Sep 2025
Transactions value $
$0
Form type
3
Filing time
08 Oct 2025, 21:00:14 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hill Christopher James Chief Financial Officer C/O ADAPTIMMUNE THERAPEUTICS PLC, 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, UNITED KINGDOM /s/ Christopher James Hill 08 Oct 2025 0002090619

No securities are beneficially owned.